Atrial fibrillation (AF) affects more than 33 million individuals worldwide 1 and has a complex heritability 2 . We conducted the largest meta-analysis of genome-wide association studies (GWAS) for AF to date, consisting of more than half a million individuals, including 65,446 with AF. In total, we identified 97 loci significantly associated with AF, including 67 that were novel in a combined-ancestry analysis, and 3 that were novel in a European-specific analysis. We sought to identify AF-associated genes at the GWAS loci by performing RNAsequencing and expression quantitative trait locus analyses in 101 left atrial samples, the most relevant tissue for AF. We also performed transcriptome-wide analyses that identified 57 AF-associated genes, 42 of which overlap with GWAS loci. The identified loci implicate genes enriched within cardiac developmental, electrophysiological, contractile and structural pathways. These results extend our understanding of the biological pathways underlying AF and may facilitate the development of therapeutics for AF.
3
. Prior genome-wide association studies (GWAS) have identified at least 30 loci associated with AF [4] [5] [6] [7] [8] [9] . We conducted a large-scale analysis with more than half a million participants, including 65,446 with AF, from more than 50 studies. Our AF sample was composed of 84.2% European, 12.5% Japanese, 2% African American and 1.3% Brazilian and Hispanic populations (Supplementary Table 1 ). We used the Haplotype Reference Consortium (HRC) reference panel to impute variants from SNP array data for 75% of the samples (Fig. 1) . In the remainder, we included HRC overlapping variants from 1000 Genomes imputed data, or from a combined reference panel. We analyzed 8,328,530 common variants (minor allele frequency (MAF) > 5%), 2,884,670 low-frequency variants (1%< MAF≤ 5%) and 936,779 rare variants (MAF ≤ 1%).
The combined-ancestry meta-analysis revealed 94 AF-associated loci, 67 of which were novel at genome-wide significance (P value (P) < 1 × 10
−8
). This conservative threshold accounts for testing independent variants with MAF ≥ 0.1% using a Bonferroni correction, while use of a more commonly utilized threshold of 5 × 10 −8 resulted in the identification of an additional 10 loci (Supplementary Table 2 ). The majority of sentinel variants (n = 92) were common (MAF > 5%), with relative risks ranging from 1.04 to 1.55. Two low-frequency sentinel variants were identified within the genes C1orf185 and UBE4B (Fig. 2 , Table 1, Supplementary Table 3 and Supplementary Fig. 1 ).
We then conducted a gene set enrichment analysis with the results from the combined-ancestry meta-analysis using MAGENTA. We identified 55 enriched gene sets or pathways that largely fall into cardiac developmental, electrophysiological, and cardiomyocyte contractile or structural functional groups (Supplementary Table  4 ). In total, 48 of the 67 novel loci contain one or more genes within 500 kilobases (kb) of the sentinel variant that were part of an enriched gene set or pathway ( Supplementary Fig. 2 ).
Next, we performed ancestry-specific meta-analyses. Among individuals of European ancestry, we identified three additional loci associated with AF, each of which had a subthreshold association (P < 1 × 10
) in the combined-ancestry meta-analysis. These loci were located close to or within the genes CDK6, EPHA3 and GOSR2 (Supplementary Table 5 and Supplementary Figs. 3 and  4) . The region most significantly associated with AF in European, Japanese and African American populations (Supplementary Figs. 5 and 6) was on chromosome 4q25, upstream of the gene PITX2 ( Supplementary Fig. 7 ). We did not observe significant heterogeneity of effect estimates across ancestries for most associations, suggesting that top genetic susceptibility signals for AF have a relatively constant effect across ancestries (Table 1, Supplementary Table 3 and Supplementary Fig. 8 ). The proportion of heritability explained by the loci from the European ancestry analysis was 42%, compared to the previously reported 25% (ref. 10 and Supplementary Table 6 ). In conditional and joint analyses of the European ancestry results, we found 11 loci with multiple, independent AF-associated signals. At a locus centered on a cluster of sodium-channel genes, we identified three regions that independently associate with AF within SCN10A, SCN5A and a third signal between both genes. At the previously described TBX5 locus 8 , we detected a novel independent signal close to TBX3. Pairwise linkage disequilibrium (LD) estimates between the independent variants at both loci were extremely low (r 2 < 0.03; Supplementary Table 7 ). For 13 AF loci, the sentinel variant or a proxy (r 2 > 0.6) was a missense variant. A missense variant (rs11057401) in CCDC92 was predicted to be damaging by four of five in silico prediction algorithms (Supplementary Table 8) ; and was previously associated with coronary artery disease 11 . Since most AF-associated variants reside in non-coding regions, we sought to determine whether the sentinel variants or their proxies (r 2 > 0.6) fell within regulatory regions in heart tissues based on chromatin states from the Roadmap Epigenomics Consortium. At 64 out of 67 novel loci, variants were located within regulatory elements (Supplementary Table 9) ; AF-associated loci were also significantly enriched within regulatory elements ( Supplementary Fig. 9 ).
We then sought to link risk variants to candidate genes by assessing their effect on gene expression levels. First, since AF often arises from the pulmonary veins and left atrium (LA), we performed RNA-sequencing, genotyping and expression quantitative trait locus (eQTL) analyses in 101 human LA samples without structural heart disease from the Myocardial Applied Genomics Network repository. Second, we identified eQTLs from right atrial (RA) and left ventricular (LV) cardiac tissue from the Genotype-Tissue Expression (GTEx) project. Finally, we performed a transcriptome-wide analysis using the MetaXcan 12 method, which infers the association between genetically predicted gene expression and disease risk.
We observed eQTLs to 1 or more genes at 17 novel loci. Of the ten eQTLs detected in LA tissue, eight were also detected in RA or LV, with consistent directionality. For example, we observed that rs4484922 was an eQTL for CASQ2 only in LA tissue. Although we detected more AF loci with eQTLs in the RA or LV data, for many of these (n = 8) the results pointed to multiple genes per locus (Supplementary  Tables 10-12 ). LA eQTL studies may facilitate the prioritization of candidate genes, but are currently limited by sample size.
Multi-ethnic genome-wide association study for atrial fibrillation
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For the transcriptome-wide analyses, we used GTEx human atrial and ventricular expression data as a reference. We identified 57 genes significantly associated with AF. Of these, 42 genes were located at AF loci, whereas the remaining 15 were > 500 kb from an AF sentinel variant (Supplementary Table 13 and Fig. 3 ). The probable candidate genes at each locus are summarized in Supplementary  Table 12. For example, at the locus with the lead variant rs4484922, we observed results from all downstream analyses pointing towards the nearest gene CASQ2, at rs12908437 towards the gene IGFR1, and at rs113819537 towards the gene SSPN. However, for many loci, the evaluation of candidate genes remains challenging.
We then sought to assess the pleiotropic effects of the identified AF risk variants. First, we queried the NHGRI-EBI GWAS Catalog to detect associations to other phenotypes (Supplementary  Table 14) . Second, using the UK Biobank 13 , we performed a phenome-wide association study (PheWAS) for 12 AF risk factors (Supplementary Table 15 ). As illustrated in Fig. 4 , distinct clusters of variants were associated with AF as well as height, body mass index and hypertension. For example, we observed a pleiotropic effect at rs880315 (CASZ1) for blood pressure 14 and hypertension 14 , which was also observed in the UK Biobank (association with hypertension, P = 2.56 × 10 −34 ). In sum, we identified a total of 97 distinct AF loci from 65,446 AF cases and more than 522,000 referents. A recent study reported 111 loci from 60,620 AF cases and more than 970,000 referents 15 , including more than 18,000 AF cases from our previous report 8 . We therefore performed a preliminary meta-analysis for the top loci in non-overlapping participants from these two large efforts, with a resulting total of more than 93,000 AF cases and more than 1 million referents. In aggregate, we identified at least 134 distinct AF-associated loci (Supplementary Table 16 ).
Four major themes emerge from the identified AF loci. First, two AF loci contain genes that are primary targets for current antiarrhythmic medications used to treat AF. The SCN5A gene encodes a sodium channel in the heart, the target of sodium-channel blockers such as flecainide and propafenone. Similarly, KCNH2 encodes the alpha subunit of the potassium channel complex, the target of potassium-channel-inhibiting medications such as amiodarone, sotalol and dofetilide. SCN5A and KCNH2 have previously been implicated in AF through GWAS 8 , candidate gene analysis 16 and family-based studies 17, 18 . Second, transcriptional regulation appears to be a key feature of AF etiology. TBX3 and the adjacent gene TBX5 encode transcription factors that have been shown to regulate the development of the cardiac conduction system 19 . Similarly, NKX2-5 encodes a transcription factor that is an early cue for cardiac development and has been associated Fig. 2 | Manhattan plot of combined-ancestry meta-analysis. The plot shows 67 novel (red) and 27 known (blue) genetic loci associated with AF at a significance level of P < 1 × 10 −8 (dotted line), for the combinedancestry meta-analysis (n = 588,190). The significance level accounts for multiple testing of independent variants with MAF ≥ 0.1% using a Bonferroni correction. P values (two-sided) were derived from a metaanalysis using a fixed-effects model with an inverse-variance weighted approach. The y axis has a break between -log 10 (P) of 30 and 510 to emphasize the novel loci. Sentinel variants at novel genetic loci associated with AF at a significance level of P < 1 × 10 −8 , for the combined-ancestry meta-analysis (n = 588,190). The significance level accounts for multiple testing of independent variants with MAF ≥ 0.1% using a Bonferroni correction. P META (two-sided) was derived from a meta-analysis using a fixed-effects model with an inverse-variance weighted approach. P HET was derived from a Cochran's Q-test (two-sided) for heterogeneity. Chr, chromosome; CI, confidence interval; Func, functional consequence (most severe consequence by variant effect predictor); HET, heterogeneity; I 2 , I-square; impQual, average imputation quality; META, meta-analysis; P, P value; RAF, risk allele frequency; reg, region; ref, reference; RR, relative risk. a Reported is either the gene that overlaps with the sentinel variant or the nearest gene(s) up-and downstream of the sentinel variant (separated by a comma). Table 14) . Further, reduced function of the transcription factor encoded by PITX2 has been associated with AF, shortening of the left atrial action potential and modulation of sodium-channel-blocker therapy in the adult LA [22] [23] [24] . A transcriptional co-regulatory network governed by transcription factors encoded by TBX5 and PITX2 has been shown to be critical for atrial development 25 . Third, the transcriptome-wide analyses revealed a number of compelling findings. Decreased expression of PRRX1 associated with AF, a result consistent with findings where reduction of PRRX1 in zebrafish and stem cell-derived cardiomyocytes was associated with action potential shortening 26 . Further, increased expression of TBX5 and KCNJ5 was associated with AF, a finding consistent with gain-of-function mutations in TBX5 reported in a family with HoltOram syndrome and a high penetrance of AF 27 . Similarly, KCNJ5 encodes a potassium channel that underlies a component of the I KAch current, a channel that is upregulated in AF. Thus, previous studies support both the role of PRRX1, TBX5 and KCNJ5 in AF and the observed directionality.
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Table 1 | Novel loci in combined-ancestry meta-analysis (continued)
Fourth, many of the novel loci implicate genes that underlie Mendelian forms of arrhythmia syndromes. Mutations in CASQ2 lead to catecholaminergic polymorphic ventricular tachycardia 28, 29 . Pathogenic variants in PKP2 impair cardiomyocyte communication and structural integrity, and are a common cause of arrhythmogenic right ventricular cardiomyopathy 30, 31 . Mutations in GJA5, KCNH2, SCN5A, KCNJ2, MYH7 and NKX2-5 have been mapped in a variety of inherited arrhythmia, cardiomyopathy or conduction system diseases 32 . Our observations highlight the pleiotropy of variation in genes specifying cardiac conduction, morphology and function, and underscore the complex, polygenic nature of AF.
In conclusion, we conducted the largest AF meta-analysis to date and report a more than threefold increase in the number of loci associated with this common arrhythmia. Our results lay the groundwork for functional evaluations of genes implicated by AF risk loci. Our findings also broaden our understanding of biological pathways involved in AF and may facilitate the development of therapeutics for AF. rs2145274  rs242557  rs6882776  rs3822259  rs6462078  rs7789146  rs295114  rs9953366  rs3176326  rs62483627  rs2834618  rs74910854  rs6790396  rs11773845  rs11264280  rs4855075  rs2306272  rs7219869  rs56181519  rs60212594  rs6742276  rs3960788  rs1044258  rs949078  rs12044963  rs10760361  rs74022964  rs11598047  rs72700114  rs55734480  rs10873299  rs76097649  rs608930  rs187585530  rs55754224  rs2129977  rs880315  rs2540949  rs6993266  rs7978685  rs62011291  rs10520260  rs17079881  rs8073937  rs4743034  rs7919685  rs12298484  rs4951261  rs4385527  rs12908437  rs10165883  rs2738413  rs12810346  rs174048  rs35504893 . P values (two-sided) were derived from linear and logistic regression models. Listed next to each trait is the number of cases for binary traits or the total sample size for quantitative traits. Hierarchical clustering was performed on a variant level using the complete linkage method based on Euclidian distance. Coloring represents Z scores for each respective trait or disease, oriented toward the AF risk allele. Red indicates an increase in the trait or disease risk while blue indicates a decrease in the trait or disease risk. BMI, body mass index; CAD, coronary artery disease; PVD, peripheral vascular disease.
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Methods
Methods, including statements of data availability and any associated accession codes and references, are available at https://doi. org/10.1038/s41588-018-0133-9. 
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We excluded samples with sex mismatches, outliers in heterozygosity and missing rates, samples that carry sex chromosome configurations other than XX or XY and samples that were excluded from the kinship inference procedure as flagged in the UKBB QC file. We further removed one sample for each pair of third-degree or closer relatives (kinship coefficient > 0.0442), preferentially keeping samples with AF case status. Primary analyses for all other studies were performed at the study sites and the summary level data of the results were provided. Prevalent cases were analyzed in a logistic regression model and most incident cases were analyzed in a Cox proportional hazards model. Studies with both prevalent and incident cases analyzed these either separately using a logistic regression model or a Cox proportional hazards model respectively, or jointly in a logistic regression model. The following tools were used for primary GWAS: ProbABEL 46 , SNPTEST 47 , FAST 48 , mach2dat (http://www.unc.edu/~yunmli/software.html), R 49 , EPACTS (http://genome.sph.umich.edu/wiki/EPACTS), Hail (https://github.com/hail-is/ hail) and PLINK 42 (Supplementary Table 18 ). Summary-level results were filtered, keeping variants with imputation quality > 0.3 and MAF × imputation quality × N events ≥ 10. We performed post-analysis QC of the summary-level results for each study. We checked reported allele frequencies against allele frequencies from imputation reference panels by ancestry. We inspected Manhattan plots for spurious associations and quantile-quantile plots to identify genomic inflation. We also calculated the genomic inflation factor (λ GC ) for each study (Supplementary  Table 18 ). Furthermore, we plotted the reported P value versus the P value derived from the Z score (effect/SE) to check for consistency of results. We checked the distribution of effect estimates and standard errors and confirmed that known AF risk variants 5 showed consistent directionality with reported effect estimates.
Meta-analyses.
Summary-level results were meta-analyzed jointly with METAL (released on March 25, 2011) using a fixed-effects model with an inverse-variance weighted approach, correcting for genomic control 50 . Separate meta-analyses were conducted for each ancestry. The results for the Japanese-specific 9 and Hispanicspecific 8 analyses have previously been reported and therefore their ancestryspecific results are not shown. Variants were included if they were present in at least two studies and showed an average MAF ≥ 0.1%. To correct for multiple testing, a genome-wide significance threshold of P < 1 × 10 −8 was applied for each analysis. This threshold is based on a naive Bonferroni correction for independent variants with MAF ≥ 0.1%, using an LD threshold of r 2 < 0.8 to estimate the number of independent variants based on European-ancestry LD 51 . As these meta-analyses are based on effect estimates and standard errors from both logistic regression and Cox proportional hazards regression, we report variant effects as relative risk, calculated as the exponential of effect estimates. For sentinel variants reaching genome-wide significance in the combined ancestry meta-analysis, we assessed whether effect estimates were homogeneous across ancestries by calculating an I 2 statistic 52 across ancestry-specific meta-analyses. We account for multiple testing across 94 variants using a Bonferroni correction, resulting in a significance threshold of P < 5.32 × 10 −4 for the heterogeneity test.
Broad AF LD reference and proxies. A LD reference file was created including 26,796 European ancestry individuals from the Broad AF study. The LD reference was based on HRC-imputed genotypes. Monomorphic variants and variants with imputation quality < 0.1 were removed before conversion to hard calls. A genotype probability threshold filter of > 0.8 was applied during hard call conversion. For multi-allelic sites, the more common alleles were kept. Variants were included in the final reference file if the variant call rate was > 70%. We identified proxies of sentinel variants as variants in LD of r 2 > 0.6 based on the Broad AF LD reference file, using PLINK v1.90 42 .
Meta-analysis of provisional loci. We meta-analyzed 111 variants from externally reported 15 provisional loci within predominantly non-overlapping samples from the Broad AF study, BBJ, EGCUT, PHB, SiGN and the Vanderbilt AF Registry with METAL (released on March 25, 2011) 50 . The predominantly non-overlapping samples included a total of 32,957 AF cases and 83,546 referents, with minimal overlap from the studies MGH AF, BBJ and AFLMU. We subsequently metaanalyzed these results with the reported provisional results with METAL using a fixed-effects model with an inverse-variance weighted approach. We analyzed a total of 93,577 AF cases and 1,053,762 referents. We compared our discovery results with the provisional loci using the same significance cutoff of P < 5 × 10 −8
for both results. Overlapping loci were identified if the reported sentinel variants were located within 500 kb of each other. For overlapping loci with differing sentinel variants, we calculated the LD between the sentinel variants, based on the Broad AF LD reference panel of European ancestry.
Variant consequence on protein-coding sequence. The most severe consequence for variants was identified with the Ensembl Variant Effect Predictor version 89.7 using RefSeq as a gene reference and the option 'pick' to identify one consequence per variant with the default pick order 53 . We queried sentinel variants and their proxies to identify tagged variants with HIGH and MODERATE impact including the following consequences: 'transcript_ablation' , 'splice_acceptor_variant' , 'splice_donor_variant' , 'stop_gained' , 'frameshift_variant' , 'stop_lost' , 'start_lost' , 'transcript_amplification' , 'inframe_insertion' , 'inframe_deletion' , 'missense_variant' Methods Samples. Participants from more than 50 studies were included in this analysis. Participants were collected from both case-control studies for AF and populationbased studies. The majority of studies were part of the Atrial Fibrillation Genetics (AFGen) consortium and the Broad AF study (Broad AF). Additional summarylevel results from the UK Biobank (UKBB) and Biobank Japan (BBJ) were included (Fig. 1) . Cases include participants with paroxysmal or permanent AF, or atrial flutter, and referents were free of these diagnoses. Adjudication of AF for each study is described in the Supplementary Notes. Ascertainment of AF in the UKBB includes samples with one or more of the following codes: non-cancer illness code, self-reported (1471, 1483); operation code (1524); diagnoses -main/secondary ICD10 (I48, I48.0-4, I48.9); underlying (primary/secondary) cause of death: ICD10 (I48, I48.0-4, I48.9); diagnoses -main/secondary ICD9 (4273); operative procedures -main/secondary OPCS (K57.1, K62.1-4) 8, 10, 33 . Baseline characteristics for each study are reported in Supplementary Table 17 . We analyzed 55,114 cases and 482,295 referents of European ancestry, 1,307 cases and 7,660 referents of African American ancestry, 8,180 cases and 28,612 referents of Japanese ancestry, 568 cases and 1,096 referents from Brazil, and 277 cases and 3,081 referents of Hispanic ethnicity. Samples from the UKBB, the Broad AF study and some studies from the AFGen consortium (SiGN, EGCUT, PHB and the Vanderbilt Atrial Fibrillation Registry) were previously not included in primary AF GWAS discovery analyses. There is minimal sample overlap from the studies MGH AF, BBJ and AFLMU between this and previous analyses. Ethics approval for participation was obtained individually by each study. All relevant ethical regulations were followed for this work. Written informed consent was obtained from all study participants.
The Institutional Review Board (IRB) at Massachusetts General Hospital reviewed and approved the overall study.
Genotyping and genotype calling. Samples within the Broad AF study were genotyped at the Broad Institute using the Infinium PsychArray-24 v1.2 Bead Chip. They were genotyped in 19 batches, grouped by origin of the samples and with a balanced case-control mix on each array. . Batch-specific quality control (QC) was performed on each call set including > 95% sample call rate, Hardy-Weinberg equilibrium P > 1 × 10 −6 and variant call rate > 97%. For common variants, a consensus merge was performed between the call sets from GenomeStudio and Birdseed. For each genotype, only concordant calls between the two algorithms were kept. The common variants from the consensus call were then combined with the rare variant calls from the zCall algorithm. Samples from all batches were joined before performing pre-imputation QC steps. Detailed procedures for genotyping and genotype calling for the SiGN study 36 , the UKBB 37 and BBJ 9 are described elsewhere. Details on genotyping and calling for all participating studies are listed in Supplementary Table 18 .
Imputation. Pre-imputation QC filtering of samples and variants was conducted according to recommended guidelines as described in Supplementary Table 19 . QC steps were performed by each study and are described in Supplementary Table 18 Supplementary Table 18 .
Primary statistical analyses. Genome-wide association testing on autosomal chromosomes was performed using an additive genetic effect model based on genotype probabilities. Each ancestry group was analyzed separately for each study. For the Broad AF study, the primary statistical analysis was performed jointly on unrelated individuals, excluding one of each pair for related samples with PI_HAT > 0.2 as calculated in PLINK v1.90 42 . Samples with sex mismatches and sample call rate < 97% were excluded. Ancestry groups were defined with ADMIXTURE 43 based on genotyped, independent and high-quality variants, using the supervised method with 1000 Genomes phase 1 v3 samples as a reference. A cutoff of 80% European ancestry was used to define the European subset and a cutoff of 60% African ancestry was used to define the African American subset. A Brazilian cohort within the Broad AF study was analyzed separately. Principal components were calculated within each ancestry group with the smartpca program from EIGENSOFT v6.1.1 44 . For the UKBB, a European subset was selected within samples with self-reported white race (British, Irish or other) and similar genetic ancestry. Genetic similarity was defined with the aberrant 45 package in R based on principal components, following the same method as described for the UKBB 37 .
(GCTA v1. 25.2) 69 using a stepwise selection procedure to identify independently associated variants on each chromosome. We used the Broad AF LD reference file for LD calculations.
Gene set enrichment analysis. A meta-analysis gene-set enrichment of variant associations (MAGENTA) v2.4 70 was performed with a combined gene set input database (GO_PANTHER_INGENUITY_KEGG_REACTOME_BIOCARTA) based on publicly available data. The analysis was conducted using the summarylevel results from the combined ancestry meta-analysis. A total of 4,045 gene sets were included and multiple testing was corrected via FDR. Gene sets were manually assigned to one or more of the following functional groups: developmental, electrophysiological, contractile/structural, and other. Genes within 500 kb of a sentinel variant were identified on the basis of the longest spanning transcribed region in the RefSeq gene reference. For each gene set, genes close to significant loci were listed. The selected genes were assigned to one or more functional groups based on their affiliation to gene sets. Functional groups from gene sets with a single label were preferentially assigned.
Association with other phenotypes. To determine whether the sentinel AF risk variants had associations with other phenotypes, two sources of data were used.
GWAS catalog. We queried the NHGRI-EBI Catalog of published GWAS 71, 72 (accessed August 31, 2017) to detect associations of AF risk variants with other phenotypes.
UKBB PheWAS.
A PheWAS was conducted in the UKBB in European-ancestry individuals. Ancestry definition and sample QC exclusions were performed in the same manner as for the primary statistical analysis, as described above. We further removed one sample for each pair of second-degree or closer relatives (kinship coefficient > 0.0884), preferentially keeping the sample with case status or non-missing phenotype. We included the following phenotypes: height, body mass index, smoking, hypertension, heart failure, stroke, mitral regurgitation, bradyarrhythmia, peripheral vascular disease, hypercholesterolemia, coronary artery disease and type II diabetes. Phenotype definitions are shown in Supplementary Table 21 . The number of samples analyzed, and case and referent counts for each phenotype, are listed in Supplementary Table 22 . Binary phenotypes were analyzed with a logistic regression model and quantitative phenotypes with a linear regression model using imputed genotype dosages in PLINK 2.00 42 . As covariates, we included sex, age at first visit, genotyping array and the first ten principal components.
Proportion of heritability explained. We calculated SNP-heritability (h 2 g ) of AF-associated loci with the REML algorithm in BOLT-LMM v2.2 73 in 120,286 unrelated samples of European ancestry from a subset of the UKBB data set comprising a prior interim release as previously described in separate work from our group 10 . We defined loci on the basis of a 1 Mb (± 500 kb) window around 84 sentinel variants from the European-ancestry meta-analysis. We transformed the h 2 g estimates into liability scale (AF prevalence = 2.45% in the UKBB). We then calculated the proportion of h . We looked for chromatin states occurring in any included tissues as well as chromatin states occurring in heart tissue. Heart tissues include: E065, aorta; E083, fetal heart; E095, left ventricle; E104, right atrium; E105, right ventricle.
Regulatory region enrichment. One thousand sets of control loci were generated by matching SNPs to sentinel variants from the AF combined-ancestry analysis, with the SNPSnap 60 tool. We used the European 1000 Genomes Phase 3 population to match via MAF, gene density, distance to nearest gene and LD buddies using r 2 > 0.6 as the LD cutoff and otherwise default settings. We excluded input SNPs and HLA SNPs from the matched SNPs. Loci were defined as SNPs and their proxies with r 2 > 0.6 based on LD from the European 1000 Genomes Phase 3 population. We identified SNPs in regulatory regions across all tissues and in cardiac tissues (E065, E095, E104 and E105) based on the Roadmap Epigenomics Consortium 25-state model (2015) 58 using HaploReg v4 59 . Regulatory regions included the following states: 2_PromU, 3_PromD1, 4_PromD2, 9_TxReg, 10_TxEnh5, 11_TxEnh3, 12_TxEnhW, 13_EnhA1, 14_EnhA2, 15_EnhAF, 16_EnhW1, 17_EnhW2, 18_EnhAc, 19_DNase, 22_PromP and 23_PromBiv. We calculated the percentage of overlap of each annotation per locus, defined as the number of SNPs per locus that fall in regulatory regions divided by the total number of SNPs per locus. Statistical significance was calculated with a permutation test from the perm package in R 61 .
eQTL. Variants identified from GWAS were assessed for overlap with eQTLs from two sources.
LA tissue from the Myocardial Applied Genomics Network (MAGNet) repository.
We performed RNA-sequencing on 101 LA tissue samples from the MAGNet repository (http://www.med.upenn.edu/magnet/) on the Illumina HiSeq 4000 platform at the Broad Institute Genomic Services. LA tissue was obtained at the time of cardiac transplantation from normal donors with no evidence of structural heart disease. All left atrial samples were from individuals of European ancestry. A summary of the clinical characteristics for these samples is shown in Supplementary Table 20 . Reads were aligned to the reference genome by STAR v2.4.1a 62 and assigned to genes based on the GENCODE gene annotation 63 . Gene expression was measured in fragments per kilobase of transcript per million mapped reads and subsequently quantile-normalized and adjusted for age, sex and the first ten principal components. Genotyping was performed on the Illumina OmniExpressExome-8v1 array and imputed to the HRC reference panel. Principal components were calculated with the smartpca program from EIGENSOFT v6.1.1 44 and European ancestry was confirmed by assessing principal components in the samples combined with 1000 Genomes European samples 40 . Associations between gene expression and genotypes were tested in a linear regression model with QTLtools v1.0 64 , to detect cis-eQTLs, defined as eQTLs within 1 Mb of the transcription start site of a gene. To account for multiple testing, an empirical false discovery rate (FDR) was used to identify significant eQTLs with a FDR < 5%.
GTEx project. We queried the GTEx 65 version 6p database for cis-eQTLs with significant associations to gene expression levels in the two available heart tissues: LV and RA appendage 66 .
Association between predicted gene expression and risk of atrial fibrillation.
To investigate transcriptome-wide associations between predicted gene expression and AF disease risk, we employed the method MetaXcan v0.3.5 12 . MetaXcan extends the previous method PrediXcan 67 to predict the association between gene expression and a phenotype of interest, using summary association statistics. Gene expression prediction models were generated from eQTL data sets using ElasticNet to identify the most predictive set of SNPs. Only models that significantly predict gene expression in the reference eQTL data set (FDR < 0.05) were considered. Pre-computed MetaXcan models for the two available heart tissues (LV and RA appendage) in the GTEx project version 6p 66 were used to predict the association between gene expression and risk of AF. Summary-level statistics from the combined ancestry meta-analysis were used as input. A total of 4,859 genes were tested for LV and 4,467 genes were tested for RA appendage. Bonferroni correction was applied to account for the number of genes tested across both tissues, resulting in a significance threshold of P < 5.36 × 10 
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